Transition from mild cognitive impairment to normal cognition: Determining the predictors of reversion with multi‐state Markov models

Introduction The theoretical framework of the Alzheimer's disease continuum considers transition between stages in a unidirectional manner. Here we examine the rate of reversion from mild cognitive impairment (MCI) to normal cognition (NC) and explore a set of potential variables associated wit...

Full description

Saved in:
Bibliographic Details
Published inAlzheimer's & dementia Vol. 18; no. 6; pp. 1177 - 1185
Main Authors Sanz‐Blasco, Rubén, Ruiz‐Sánchez de León, José M., Ávila‐Villanueva, Marina, Valentí‐Soler, Meritxel, Gómez‐Ramírez, Jaime, Fernández‐Blázquez, Miguel A.
Format Journal Article
LanguageEnglish
Published United States 01.06.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Introduction The theoretical framework of the Alzheimer's disease continuum considers transition between stages in a unidirectional manner. Here we examine the rate of reversion from mild cognitive impairment (MCI) to normal cognition (NC) and explore a set of potential variables associated with this phenomenon. Methods A total of 985 Spanish community‐dwelling individuals aged 70 years and over at baseline were monitored for 5 years. During this time, 173 MCI and 36 dementia cases were identified. Multi‐state Markov models were performed to characterize transitions between states through the dementia continuum. Results The rate of reversion from MCI to NC was 11%. There were significant non‐modifiable (age, socioeconomic status, or apolipoprotein E) and modifiable factors (cognitive training or absence of affective symptoms) associated with reversion. Discussion Overall, our results highlight that the likelihood of progression from MCI to dementia is very similar to that of reversion from MCI to NC.
Bibliography:Jaime Gómez‐Ramírez, and Miguel A. Fernández‐Blázquez contributed equally to this work
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1552-5260
1552-5279
DOI:10.1002/alz.12448